Cargando…

Perioperative Management of Type 2N Von Willebrand's Disease with Recombinant Factor VIII in a Patient Undergoing Knee-Replacement Surgery

Type 2N Von Willebrand's disease (2N VWD) is a rare, recessively inherited bleeding disorder, comprising 1-2% of all VWD patients, usually manifesting as a mild bleeding diathesis. Treatment includes desmopressin (DDAVP) or intermediate purity plasma-derived FVIII concentrates containing residu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dukka, Srivasavi, Allsup, David John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575673/ https://www.ncbi.nlm.nih.gov/pubmed/23431487 http://dx.doi.org/10.1155/2013/837906

Ejemplares similares

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2016)

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery
por: Peyvandi, F., et al.
Publicado: (2018)

Subcellular platelet factor VIII antigen and von Willebrand factor
Publicado: (1975)

How to keep the factor VIII/von Willebrand factor complex in the circulation
por: Denis, Cécile V., et al.
Publicado: (2021)

Subunit Flexibility of Multimeric von Willebrand Factor/Factor VIII Complexes
por: Parker, Ernest T., et al.
Publicado: (2022)

Mechano-covalent protection of coagulation factor VIII by von Willebrand factor
por: Butera, Diego, et al.
Publicado: (2022)

Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
por: Jimenez‐Yuste, Victor, et al.
Publicado: (2021)

Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study
por: Goudemand, Jenny, et al.
Publicado: (2020)

Factors VIII and Von Willebrand Levels in Women Undergoing Assisted Reproduction: Are Their Levels Associated with Clinical Pregnancy Outcome?
por: Attanasio, Monica, et al.
Publicado: (2020)

Administration of plasma-derived coagulation factor VIII during the perioperative period of mastectomy for breast cancer with acquired von Willebrand syndrome
por: Sasaki, Ritsuko, et al.
Publicado: (2018)

Conformation of the von Willebrand factor/factor VIII complex in quasi-static flow
por: Parker, Ernest T., et al.
Publicado: (2021)

An intensive approach to treatment for older patients with relapsed isolated NPM1 mutated AML
por: Dukka, Srivasavi, et al.
Publicado: (2015)

Perioperative management of von Willebrand patients at the time of implant placement: Case report
por: Takashima, Hiroyuki, et al.
Publicado: (2021)

Successful desensitization in a patient with Von Willebrand´s disease and anaphylaxis to factor VIII/VW
por: Olival, Maristela, et al.
Publicado: (2014)

Cerebral Sinus and Venous Thrombosis Associated with von Willebrand Factor, Independently of Factor VIII
por: Terashima, Mari, et al.
Publicado: (2008)

Presence of factor VIII-related antigen in blood platelets of patients with Von Willebrand's disease
por: BOUMA, B. N., et al.
Publicado: (1975)

Acquired von Willebrand syndrome and factor VIII in patients with moderate to severe mitral regurgitation undergoing transcatheter mitral valve repair
por: Meindl, Christine, et al.
Publicado: (2020)

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
por: Leebeek, Frank W. G., et al.
Publicado: (2022)

Cleavage of von Willebrand Factor by Granzyme M Destroys Its Factor VIII Binding Capacity
por: Hollestelle, Martine J., et al.
Publicado: (2011)

Paroxysmal atrial fibrillation: changes in factor VIII and von Willebrand factor impose early hypercoagulability
por: Negreva, Mariya Negrinova, et al.
Publicado: (2020)

Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis
por: Praktiknjo, Michael, et al.
Publicado: (2020)

Polyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitro
por: Montilla, Marcela, et al.
Publicado: (2022)

Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding
por: Casini, Alessandro, et al.
Publicado: (2023)

Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease
por: Lapić, Ivana, et al.
Publicado: (2022)

Perioperative management of a pediatric patient with suspected type 1 von Willebrand disease undergoing tonsillectomy: a case report
por: Oshika, Hiroyuki, et al.
Publicado: (2019)

In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor
por: Colling, Meaghan E., et al.
Publicado: (2019)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
por: Gritsch, Herbert, et al.
Publicado: (2022)

Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
por: Bauer, Alexander, et al.
Publicado: (2023)

Outcomes in Patients With von Willebrand Disease Receiving Recombinant von Willebrand Factor on Demand and in Surgical Settings: Chart Review
por: Sun, Shawn X., et al.
Publicado: (2023)

The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial
por: Kovacevic, Katarina D., et al.
Publicado: (2021)

Von Willebrand's Disease: Pathogenesis and Management
por: Dormandy, Katharine M.
Publicado: (1969)

Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function
Publicado: (1982)

Interaction Between the a3 Region of Factor VIII and the TIL’E’ Domains of the von Willebrand Factor
por: Dagil, Lisbeth, et al.
Publicado: (2019)

ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients
por: Escher, R., et al.
Publicado: (2020)

Severe Traumatic Brain Injury in a Patient with von Willebrand Disease Type 2A Successfully Treated with Factor VIII/von Willebrand Factor Concentrates: A Case Report
por: Koroki, Takatoshi, et al.
Publicado: (2022)

Storage of Factor VIII Variants with Impaired von Willebrand Factor Binding in Weibel-Palade Bodies in Endothelial Cells
por: van den Biggelaar, Maartje, et al.
Publicado: (2011)

Von Willebrand factor and coagulation factor VIII in Moyamoya disease associated with Graves' disease: A case report
por: Ren, Shou-Chen, et al.
Publicado: (2016)

Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels
por: Kiouptsi, Klytaimnistra, et al.
Publicado: (2017)

D’ domain region Arg782-Cys799 of von Willebrand factor contributes to factor VIII binding
por: Przeradzka, Małgorzata A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ckckb8jamec6ok897frgan54k1